About Elfin
Elfin is a Healthcare company based in India founded in 1999. Functions as a CDMO specializing in the manufacturing of solid drug formulations. It operates on a B2B model. The company has 19 employees. Its Indian entity Elfin Drugs Private Limited reported revenue of ₹21.23 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Drug Formulation. Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Elfin operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug formulation. Functions as a CDMO specializing in the manufacturing of solid drug formulations. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters India
- Employees 19
- SectorsHealthcare
- Website elfindrugs.com
- Social X
- Legal Name Elfin Drugs Pvt Ltd
- Date of Incorporation 25 Apr, 2005
- Jurisdiction Mohali, Punjab, India
- Annual Revenue₹21.23 Cr
FY 2024 · +15% YoY
- Net Profit₹21.1 Lakh
FY 2024 · 1% margin
- EBITDA₹1.68 Cr
FY 2024 · 8% margin
- Employee Count19
Associated legal entities of Elfin
Elfin operates through Elfin Drugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Elfin Drugs Private Limited CIN U24231PB2005PTC028300 | Active | 25 Apr 2005 | Mohali, Punjab | ₹21.2 Cr | 19 | 2 | View details |
Board of directors of Elfin Drugs Private Limited (Elfin)
Elfin Drugs Private Limited is the primary company behind Elfin. The board of Elfin Drugs Private Limited currently have 2 directors; the longest-serving is Dilpreet Singh, appointed in 2005. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dilpreet Singh DIN 01446357 | Director | 25 Apr 2005 | 21 yrs 6 mo | Elfin Drugs Private Limited |
| Surinder Jit Kaur DIN 08487523 | Director | 19 Jun 2019 | 7 yrs 4 mo | Elfin Drugs Private Limited |
Financials of Elfin
Figures of Elfin Drugs Private Limited, the primary company behind Elfin, for FY 2024. Revenue was ₹21.23 Cr (+15% year on year). Net profit was ₹21.1 Lakh (1% margin). EBITDA was ₹1.68 Cr (8% margin). Revenue has grown at a compounded annual rate of +20% over three years and +18% over five years.
- ₹21.23 CrRevenue · FY 2024 · +15% YoY
- ₹21.1 LakhNet profit · 1% margin
- ₹1.68 CrEBITDA · 8% margin
- ₹70.5 LakhPaid-up capital
- 19Employees (provident fund records)
- +20%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Elfin Drugs Private Limited are on its company page.
Detailed financial statements for Elfin
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Elfin
Elfin has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. |
Detailed competitors of Elfin
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elfin
Elfin was founded in 1999.
Elfin is headquartered in India.
Elfin has 19 employees.
The primary company behind Elfin, Elfin Drugs Private Limited, reported revenue of ₹21.23 Cr for FY 2024, up 15% year on year.
Elfin operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug formulation. Functions as a CDMO specializing in the manufacturing of solid drug formulations. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Elfin's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.
Elfin operates through Elfin Drugs Private Limited.
The legal entities of Elfin currently have 2 directors, including Dilpreet Singh, Surinder Jit Kaur.